Who is sponsoring NCT04776031?

NCT04776031 is sponsored by Lutronic Vision, Inc.

What drugs are being tested in NCT04776031?

Interventions in NCT04776031: R:GEN Laser System.

What condition does NCT04776031 study?

NCT04776031 studies Early Age Related Macular Degeneration (Disorder).

Is NCT04776031 still recruiting?

NCT04776031 is currently completed. Last updated 16 May 2023.

Last reviewed 2023-05-16 · How we verify

NCT04776031

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of R:GEN as Intervention in Subjects With Early Stages of AMD for Safety and Exploratory Efficacy Outcomes

Completed NA Last updated 16 May 2023

What this trial tests

NA trial testing R:GEN Laser System in Early Age Related Macular Degeneration (Disorder) in 31 participants. Completed in 14 March 2023.

Timeline

15 February 2021

Primary endpoint
14 March 2023

14 March 2023

Quick facts

Lead sponsor	Lutronic Vision, Inc
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	31
Start date	15 February 2021
Primary completion	14 March 2023
Estimated completion	14 March 2023
Sites	1 location across Australia

Drugs / interventions tested

R:GEN Laser System

Conditions studied

Early Age Related Macular Degeneration (Disorder) — all drugs for Early Age Related Macular Degeneration (Disorder) →

Sponsor

Lutronic Vision, Inc

Who can join

50 and older, any sex, with Early Age Related Macular Degeneration (Disorder). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the safety and tolerability of the R:GEN Laser System in subjects with the early stages of age-related macular degeneration.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04776031 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lutronic Vision, Inc
Last refreshed: 16 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04776031.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing